BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6166918)

  • 1. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
    Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L
    Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kallikrein and prekallikrein determination in a number of pathological conditions using the Centrifichem analyzer.
    Creter D; Allalouf D
    Ann Allergy; 1982 Jun; 48(6):349-50. PubMed ID: 6920247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role of the C1-esterase inhibitor in cold urticaria.
    Nilsson T; Bäck O
    Acta Derm Venereol; 1984; 64(3):197-202. PubMed ID: 6204479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).
    Cullmann W; Kövary PM; Müller N; Dick W
    Clin Exp Immunol; 1982 Sep; 49(3):618-22. PubMed ID: 7172497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.
    Gallimore MJ
    Scand J Clin Lab Invest Suppl; 1985; 178():127-32. PubMed ID: 3867113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma kallikrein and prorenin in patients with hereditary angioedema.
    Purdon AD; Schapira M; De Agostini A; Colman RW
    J Lab Clin Med; 1985 Jun; 105(6):694-9. PubMed ID: 3889200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N; Hellgren M
    Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
    Schmaier AH; Gustafson E; Idell S; Colman RW
    J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma kallikrein-kinin system in hypercoagulable state (author's transl)].
    Koie K; Kamiya T; Takamatsu J; Hayashi K; Saito H
    Rinsho Ketsueki; 1980 Jun; 21(6):704-13. PubMed ID: 6450843
    [No Abstract]   [Full Text] [Related]  

  • 15. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys.
    Bork K; Kleist R; Hardt J; Witzke G
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):325-32. PubMed ID: 19474702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation.
    Donaldson VH; Harrison RA
    Blood; 1982 Jul; 60(1):121-9. PubMed ID: 6211203
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of factor XII, plasma prekallikrein and factor V in patients with thrombophilic states].
    Stürzebecher J; Huyke R; Vogel G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):492-6. PubMed ID: 6083916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activation of C1s in plasma of patients with hereditary angioneurotic oedema.
    Shafiasghar S; Cormane RH; Pondman KW
    Clin Exp Immunol; 1976 Aug; 25(2):244-55. PubMed ID: 821682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Deficiency of Cl-esterase inhibitor in a patient with hereditary angioneurotic oedema (author's transl)].
    Starsia Z; Stefanovic J; Cáp J; Murgasová I
    Cas Lek Cesk; 1975 Oct; 114(41):1255-8. PubMed ID: 1192446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.